1. Home
  2. KRUS vs AGMB Comparison

KRUS vs AGMB Comparison

Compare KRUS & AGMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kura Sushi USA Inc.

KRUS

Kura Sushi USA Inc.

N/A

Current Price

$40.32

Market Cap

485.4M

ML Signal

N/A

Logo AgomAb Therapeutics NV American Depositary Shares

AGMB

AgomAb Therapeutics NV American Depositary Shares

N/A

Current Price

$9.17

Market Cap

576.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KRUS
AGMB
Founded
2008
2017
Country
United States
Belgium
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
485.4M
576.2M
IPO Year
2019
2024

Fundamental Metrics

Financial Performance
Metric
KRUS
AGMB
Price
$40.32
$9.17
Analyst Decision
Buy
Strong Buy
Analyst Count
9
7
Target Price
★ $67.00
$37.67
AVG Volume (30 Days)
★ 250.0K
146.0K
Earning Date
11-05-2026
11-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 79.75
N/A
EPS
N/A
★ N/A
Revenue
★ $282,763,000.00
N/A
Revenue This Year
$16.97
N/A
Revenue Next Year
$18.28
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 18.88
N/A
52 Week Low
$33.97
$7.97
52 Week High
$80.84
$17.82

Technical Indicators

Market Signals
Indicator
KRUS
AGMB
Relative Strength Index (RSI) 47.85 34.70
Support Level $33.97 N/A
Resistance Level $41.99 $12.53
Average True Range (ATR) 1.75 0.85
MACD 0.54 -0.09
Stochastic Oscillator 72.53 28.26

Price Performance

Historical Comparison
KRUS
AGMB

About KRUS Kura Sushi USA Inc.

Kura Sushi USA Inc is a technology-enabled Japanese restaurant concept that provides guests with a distinctive dining experience by serving authentic Japanese cuisine through an engaging revolving sushi service model. The company operates a chain of sushi restaurants across the United States serving freshly prepared Japanese cuisine using high-quality ingredients that are free from artificial seasonings, sweeteners, colorings, and preservatives. The company operates a network of dine-in locations across the U.S. states and Washington, DC.

About AGMB AgomAb Therapeutics NV American Depositary Shares

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.

Share on Social Networks: